Growth Metrics

Mannkind (MNKD) Operating Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.96%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -50.81%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.47%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 55.96%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 34.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 34.74%
Dec 31, 2025 15.61%
Sep 30, 2025 58.29%
Jun 30, 2025 31.21%
Mar 31, 2025 45.00%
Dec 31, 2024 45.90%
Sep 30, 2024 57.89%
Jun 30, 2024 53.50%
Mar 31, 2024 67.52%
Dec 31, 2023 32.59%
Sep 30, 2023 36.77%
Jun 30, 2023 30.40%
Mar 31, 2023 5.56%
Dec 31, 2022 -4.06%
Sep 30, 2022 -3.06%
Jun 30, 2022 -23.15%
Mar 31, 2022 -16.30%
Dec 31, 2021 -45.82%
Sep 30, 2021 32.62%
Jun 30, 2021 20.62%
Mar 31, 2021 38.63%
Dec 31, 2020 6.27%
Sep 30, 2020 31.32%
Jun 30, 2020 36.94%
Mar 31, 2020 28.65%
Dec 31, 2019 1.37%
Sep 30, 2019 -27.53%
Jun 30, 2019 16.96%
Mar 31, 2019 12.27%
Dec 31, 2018 69.52%
Sep 30, 2018 6.08%
Jun 30, 2018 5.13%
Mar 31, 2018 -7.21%
Dec 31, 2017 1.42%
Sep 30, 2017 9.70%
Jun 30, 2017 23.26%
Mar 31, 2017 22.07%
Dec 31, 2016 36.68%
Sep 30, 2016 66.81%
Jun 30, 2016 22.81%
Mar 31, 2016 18.11%
Dec 31, 2015 -101.23%
Sep 30, 2015 9.85%
Jun 30, 2015 18.27%
Mar 31, 2015 13.80%
Dec 31, 2014 0.52%
Sep 30, 2014 -5.30%
Jun 30, 2014 -21.25%
Mar 31, 2014 -2.91%
Dec 31, 2013 -13.25%
Sep 30, 2013 -1.71%
Jun 30, 2013 -3.73%